Abstract:Typhoid toxin is an A2B5 toxin secreted from Salmonella Typhi-infected cells during human infection and is suggested to contribute to typhoid disease progression and the establishment of chronic infection. To deliver the enzymatic 'A' subunits of the toxin to the site of action in host cells, the receptor-binding 'B' subunit PltB binds to the trisaccharide glycan receptor moieties terminated in N-acetylneuraminic acid (Neu5Ac) that is α2–3 or α2–6 linked to the underlying disaccharide, galactose (Gal) and N-acetylglucosamine (GlcNAc). Neu5Ac is present in both unmodified and modified forms, with 9-O-acetylated Neu5Ac being the most common modification in humans. Here we show that host cells associated with typhoid toxin-mediated clinical signs express both unmodified and 9-O-acetylated glycan receptor moieties. We found that PltB binds to 9-O-acetylated α2–3 glycan receptor moieties with a markedly increased affinity, while the binding affinity to 9-O-acetylated α2–6 glycans is only slightly higher, as compared to the affinities of PltB to the unmodified counterparts, respectively. We also present X-ray co-crystal structures of PltB bound to related glycan moieties, which supports the different effects of 9-O-acetylated α2–3 and α2–6 glycan receptor moieties on the toxin binding. Lastly, we demonstrate that the cells exclusively expressing unmodified glycan receptor moieties are less susceptible to typhoid toxin than the cells expressing 9-O-acetylated counterparts, although typhoid toxin intoxicates both cells. These results reveal a fine-tuning mechanism of a bacterial toxin that exploits specific chemical modifications of its glycan receptor moieties for virulence and provide useful insights into the development of therapeutics against typhoid fever.The Gram-negative rod-shaped bacteria Salmonella enterica serovar Typhi (S. enterica serovar Typhi or S. Typhi) is the cause of the life-threatening disease typhoid fever. Many millions of people including children under the age of five are affected by this infectious disease. Molecular mechanisms underlying typhoid disease progression and the establishment of chronic infection important for the transmission of this human-adapted pathogen are incompletely understood, but typhoid toxin, one of the virulence factors of S. Typhi, is suggested to contribute to these processes. Typhoid toxin consists of three functionally distinct subunits: two enzymatic 'A' subunits important for intoxicating host cells after the delivery into host cells and one homopentamer of receptor-binding 'B' subunit important for the delivery of the toxin into host cells. Typhoid toxin 'B' subunit recognizes specific three-sugar structures decorating the host cell surface, whose terminal sugar called N-acetylneuraminic acid (Neu5Ac) can be present in unmodified or modified forms. The modified Neu5Ac possesses additional chemical groups, with 9-O-acetylation being the most frequently found modification in humans. This study analyzes glycan expression profiles of primary tissues and cells associated with typhoid clinical signs, the interface between the toxin and glycan receptor moieties through biochemical and structural approaches, and typhoid toxin intoxication profiles of host cells that are genetically engineered to alter the expression of related glycans. This study reveals a fine-tuning mechanism of a bacterial toxin in exploiting a chemical modification of glycan receptor moieties for virulence and thus provides useful insights into the development of efficacious therapeutics against typhoid intoxication.

The role of 9-O-acetylated glycan receptor moieties in the typhoid toxin binding and intoxication

Salmonella Enterica Serovar Typhimurium Interacts with CD209 Receptors to Promote Host Dissemination and Infection

Host Adaptation of a Bacterial Toxin from the Human Pathogen Salmonella Typhi

Evolution of Host Adaptation in the Salmonella Typhoid Toxin

Emerging insights into the biology of typhoid toxin

Structure and Function of the Salmonella Typhi Chimaeric A2B5 Typhoid Toxin

Evolutionary and functional connections between the typhoid toxins encoded by S. Typhi and S. bongori

Investigation of the role of typhoid toxin in acute typhoid fever in a human challenge model

Mechanism of Gene Regulation by a Staphylococcus Aureus Toxin

A novel phospholipase A2 is a core component of the typhoid toxin genetic islet

A novel PhoP-regulated locus encoding the cytolysin ClyA and the secreted invasin TaiA of Salmonella enterica serovar Typhi is involved in virulence

Typhoid toxin of Salmonella Typhi elicits host antimicrobial response during acute typhoid fever

Alternate typhoid toxin assembly evolved independently in the two Salmonella species

Molecular correlates of vaccine-induced protection against typhoid fever

A TonB dependent transporter YncD of Salmonella enterica Serovar Typhi possesses vaccine potential

Interplay Between the Gut Microbiome and Typhoid Fever: Insights from Endemic Countries and a Controlled Human Infection Model

Incorporation of a non-human glycan mediates human susceptibility to a bacterial toxin

Early host immune responses in a human organoid-derived gallbladder monolayer to Salmonella Typhi strains from patients with acute and chronic infections: a comparative analysis

Bi-valent polysaccharides of Vi capsular and O9 O-antigen in attenuated Salmonella Typhimurium induce strong immune responses against these two antigens

TolC facilitates the intracellular survival and immunomodulation of salmonella typhi in human Host cells

The Salmonella enterica serovar Typhimurium virulence factor STM3169 is a hexuronic acid binding protein component of a TRAP transporter